Vaccine manufacturing capacity in low- and middle-income countries
Vaccination is the most cost-effective public health intervention for the control and eradication of infectious diseases, including the coronavirus disease 2019 (COVID-19). Ensuring equitable access to all vaccines is needed, particularly now with the significant global demand for vaccine doses to c...
Gespeichert in:
| Veröffentlicht in: | Bulletin of the World Health Organization 2021-07, Vol.99 (7), p.479-479A |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 479A |
|---|---|
| container_issue | 7 |
| container_start_page | 479 |
| container_title | Bulletin of the World Health Organization |
| container_volume | 99 |
| creator | Khan, Mohammed Imran Ikram, Aamer Hamzac, Hasan Bin |
| description | Vaccination is the most cost-effective public health intervention for the control and eradication of infectious diseases, including the coronavirus disease 2019 (COVID-19). Ensuring equitable access to all vaccines is needed, particularly now with the significant global demand for vaccine doses to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the focus on ensuring the availability of COVID-19 vaccines has affected the manufacturing and supply chain of other vaccines. In addition, the COVID-19 pandemic has resulted in a drop in health service use including immunization services.1 This drop will likely lead to an increase in the risk of vaccine-preventable infectious disease outbreaks. |
| doi_str_mv | 10.2471/BLT.20.273375 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8243032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A669138138</galeid><sourcerecordid>A669138138</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5115-fc0df50ccb94794909b45bc742b32ef910be96683a6c5b3720f9393b54d26a313</originalsourceid><addsrcrecordid>eNqNkkFv1DAQhSMEoqVw5B4JCcEhi-2xnfiC1FaFrlgJBIWr5TiTrKvE3sYJpf8eb1tBF-0B--An-5s3M_Jk2UtKFoyX9N3J6mLBki4BSvEoOySEs0LJSj5-oA-yZzFekrQUJ0-zA-CMV4yWh9nJD2Ot85gPxs-tsdM8Ot_l1myMddNN7nzeh-siN77JB9c0PRbO2zBgbsPsp9FhfJ49aU0f8cX9eZR9_3B2cXperD5_XJ4erworKBVFa0nTCmJtrXipuCKq5qK2JWc1MGwVJTUqKSsw0ooaSkZaBQpqwRsmDVA4yt7f-W7mesDGYkpver0Z3WDGGx2M07sv3q11F37qinEgwJLBm3uDMVzNGCc9uGix743HMEfNhCASgEOV0Ff_oJdhHn1qb0tBJSoB8i_VmR61821Iee3WVB9LqShU9Nar2EN16DEVGTy2Ll3v8Is9fNoNDs7uDXi7E5CYCX9NnZlj1J--LP-bXX77usu-fsCu0fTTOoZ-nlzwcW-Hdgwxjtj--RRK9HZKdZpSzZK-nVL4DViS0wA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2553858536</pqid></control><display><type>article</type><title>Vaccine manufacturing capacity in low- and middle-income countries</title><source>PAIS Index</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Khan, Mohammed Imran ; Ikram, Aamer ; Hamzac, Hasan Bin</creator><creatorcontrib>Khan, Mohammed Imran ; Ikram, Aamer ; Hamzac, Hasan Bin</creatorcontrib><description>Vaccination is the most cost-effective public health intervention for the control and eradication of infectious diseases, including the coronavirus disease 2019 (COVID-19). Ensuring equitable access to all vaccines is needed, particularly now with the significant global demand for vaccine doses to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the focus on ensuring the availability of COVID-19 vaccines has affected the manufacturing and supply chain of other vaccines. In addition, the COVID-19 pandemic has resulted in a drop in health service use including immunization services.1 This drop will likely lead to an increase in the risk of vaccine-preventable infectious disease outbreaks.</description><identifier>ISSN: 0042-9686</identifier><identifier>EISSN: 0042-9686</identifier><identifier>EISSN: 1564-0604</identifier><identifier>DOI: 10.2471/BLT.20.273375</identifier><identifier>PMID: 34248217</identifier><language>eng</language><publisher>Geneva: World Health Organization</publisher><subject>Capacity ; Coronaviruses ; Cost analysis ; COVID-19 ; COVID-19 vaccines ; Developing countries ; Dosage ; Epidemics ; Eradication ; Health care expenditures ; Health education ; Health promotion ; Health risks ; Health services utilization ; Immunization ; Infectious diseases ; Intervention ; LDCs ; Manufacturing ; Medical care, Cost of ; Pakistan ; Pandemics ; Production capacity ; Public health ; Respiratory diseases ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Supply ; Supply chains ; Vaccination ; Vaccines ; Viral diseases</subject><ispartof>Bulletin of the World Health Organization, 2021-07, Vol.99 (7), p.479-479A</ispartof><rights>COPYRIGHT 2021 World Health Organization</rights><rights>Copyright World Health Organization Jul 2021</rights><rights>(c) 2021 The authors; licensee World Health Organization. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5115-fc0df50ccb94794909b45bc742b32ef910be96683a6c5b3720f9393b54d26a313</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243032/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243032/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27871,27929,27930,53796,53798</link.rule.ids></links><search><creatorcontrib>Khan, Mohammed Imran</creatorcontrib><creatorcontrib>Ikram, Aamer</creatorcontrib><creatorcontrib>Hamzac, Hasan Bin</creatorcontrib><title>Vaccine manufacturing capacity in low- and middle-income countries</title><title>Bulletin of the World Health Organization</title><description>Vaccination is the most cost-effective public health intervention for the control and eradication of infectious diseases, including the coronavirus disease 2019 (COVID-19). Ensuring equitable access to all vaccines is needed, particularly now with the significant global demand for vaccine doses to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the focus on ensuring the availability of COVID-19 vaccines has affected the manufacturing and supply chain of other vaccines. In addition, the COVID-19 pandemic has resulted in a drop in health service use including immunization services.1 This drop will likely lead to an increase in the risk of vaccine-preventable infectious disease outbreaks.</description><subject>Capacity</subject><subject>Coronaviruses</subject><subject>Cost analysis</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Developing countries</subject><subject>Dosage</subject><subject>Epidemics</subject><subject>Eradication</subject><subject>Health care expenditures</subject><subject>Health education</subject><subject>Health promotion</subject><subject>Health risks</subject><subject>Health services utilization</subject><subject>Immunization</subject><subject>Infectious diseases</subject><subject>Intervention</subject><subject>LDCs</subject><subject>Manufacturing</subject><subject>Medical care, Cost of</subject><subject>Pakistan</subject><subject>Pandemics</subject><subject>Production capacity</subject><subject>Public health</subject><subject>Respiratory diseases</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Supply</subject><subject>Supply chains</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Viral diseases</subject><issn>0042-9686</issn><issn>0042-9686</issn><issn>1564-0604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>KPI</sourceid><sourceid>7TQ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkkFv1DAQhSMEoqVw5B4JCcEhi-2xnfiC1FaFrlgJBIWr5TiTrKvE3sYJpf8eb1tBF-0B--An-5s3M_Jk2UtKFoyX9N3J6mLBki4BSvEoOySEs0LJSj5-oA-yZzFekrQUJ0-zA-CMV4yWh9nJD2Ot85gPxs-tsdM8Ot_l1myMddNN7nzeh-siN77JB9c0PRbO2zBgbsPsp9FhfJ49aU0f8cX9eZR9_3B2cXperD5_XJ4erworKBVFa0nTCmJtrXipuCKq5qK2JWc1MGwVJTUqKSsw0ooaSkZaBQpqwRsmDVA4yt7f-W7mesDGYkpver0Z3WDGGx2M07sv3q11F37qinEgwJLBm3uDMVzNGCc9uGix743HMEfNhCASgEOV0Ff_oJdhHn1qb0tBJSoB8i_VmR61821Iee3WVB9LqShU9Nar2EN16DEVGTy2Ll3v8Is9fNoNDs7uDXi7E5CYCX9NnZlj1J--LP-bXX77usu-fsCu0fTTOoZ-nlzwcW-Hdgwxjtj--RRK9HZKdZpSzZK-nVL4DViS0wA</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Khan, Mohammed Imran</creator><creator>Ikram, Aamer</creator><creator>Hamzac, Hasan Bin</creator><general>World Health Organization</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>KPI</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7T2</scope><scope>7TQ</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>88J</scope><scope>8AF</scope><scope>8AO</scope><scope>8BJ</scope><scope>8C1</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DHY</scope><scope>DON</scope><scope>DPSOV</scope><scope>DWQXO</scope><scope>FQK</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>JBE</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KC-</scope><scope>L.-</scope><scope>L6V</scope><scope>M0C</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2L</scope><scope>M2O</scope><scope>M2R</scope><scope>M7S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PATMY</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210701</creationdate><title>Vaccine manufacturing capacity in low- and middle-income countries</title><author>Khan, Mohammed Imran ; Ikram, Aamer ; Hamzac, Hasan Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5115-fc0df50ccb94794909b45bc742b32ef910be96683a6c5b3720f9393b54d26a313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Capacity</topic><topic>Coronaviruses</topic><topic>Cost analysis</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Developing countries</topic><topic>Dosage</topic><topic>Epidemics</topic><topic>Eradication</topic><topic>Health care expenditures</topic><topic>Health education</topic><topic>Health promotion</topic><topic>Health risks</topic><topic>Health services utilization</topic><topic>Immunization</topic><topic>Infectious diseases</topic><topic>Intervention</topic><topic>LDCs</topic><topic>Manufacturing</topic><topic>Medical care, Cost of</topic><topic>Pakistan</topic><topic>Pandemics</topic><topic>Production capacity</topic><topic>Public health</topic><topic>Respiratory diseases</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Supply</topic><topic>Supply chains</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Mohammed Imran</creatorcontrib><creatorcontrib>Ikram, Aamer</creatorcontrib><creatorcontrib>Hamzac, Hasan Bin</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>Gale In Context: Global Issues</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>PAIS Index</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>Politics Collection</collection><collection>ProQuest Central Korea</collection><collection>International Bibliography of the Social Sciences</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Politics Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Engineering Collection</collection><collection>ABI/INFORM Global</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Political Science Database</collection><collection>Research Library</collection><collection>Social Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Environmental Science Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bulletin of the World Health Organization</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Mohammed Imran</au><au>Ikram, Aamer</au><au>Hamzac, Hasan Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccine manufacturing capacity in low- and middle-income countries</atitle><jtitle>Bulletin of the World Health Organization</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>99</volume><issue>7</issue><spage>479</spage><epage>479A</epage><pages>479-479A</pages><issn>0042-9686</issn><eissn>0042-9686</eissn><eissn>1564-0604</eissn><abstract>Vaccination is the most cost-effective public health intervention for the control and eradication of infectious diseases, including the coronavirus disease 2019 (COVID-19). Ensuring equitable access to all vaccines is needed, particularly now with the significant global demand for vaccine doses to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the focus on ensuring the availability of COVID-19 vaccines has affected the manufacturing and supply chain of other vaccines. In addition, the COVID-19 pandemic has resulted in a drop in health service use including immunization services.1 This drop will likely lead to an increase in the risk of vaccine-preventable infectious disease outbreaks.</abstract><cop>Geneva</cop><pub>World Health Organization</pub><pmid>34248217</pmid><doi>10.2471/BLT.20.273375</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0042-9686 |
| ispartof | Bulletin of the World Health Organization, 2021-07, Vol.99 (7), p.479-479A |
| issn | 0042-9686 0042-9686 1564-0604 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8243032 |
| source | PAIS Index; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Capacity Coronaviruses Cost analysis COVID-19 COVID-19 vaccines Developing countries Dosage Epidemics Eradication Health care expenditures Health education Health promotion Health risks Health services utilization Immunization Infectious diseases Intervention LDCs Manufacturing Medical care, Cost of Pakistan Pandemics Production capacity Public health Respiratory diseases Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Supply Supply chains Vaccination Vaccines Viral diseases |
| title | Vaccine manufacturing capacity in low- and middle-income countries |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T17%3A51%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccine%20manufacturing%20capacity%20in%20low-%20and%20middle-income%20countries&rft.jtitle=Bulletin%20of%20the%20World%20Health%20Organization&rft.au=Khan,%20Mohammed%20Imran&rft.date=2021-07-01&rft.volume=99&rft.issue=7&rft.spage=479&rft.epage=479A&rft.pages=479-479A&rft.issn=0042-9686&rft.eissn=0042-9686&rft_id=info:doi/10.2471/BLT.20.273375&rft_dat=%3Cgale_pubme%3EA669138138%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2553858536&rft_id=info:pmid/34248217&rft_galeid=A669138138&rfr_iscdi=true |